Case Conversation Series
The FWGBD Case Conversation Series will feature case-based presentations and discussion by leading experts in the areas of hematology and reproductive health on the diagnosis, treatment and management of blood disorders affecting women and girls across the lifespan. This virtual series will also offer a special emphasis on the ways in which collaboration between key specialists (i.e., hematology and reproductive health) augments management.
The principal goals of this virtual forum are to: (a) enhance participants’ understanding of the current state of knowledge; (b) utilize current cases to shape the discussion; (c) provide an overview of evidence-based, practical information as well as new, effective approaches to the diagnosis, testing, and assessment of disorders affecting women and girls; and (d) provide experience in reviewing and critiquing research. Each session will feature recent key articles to support the discussion. All registrants will receive a copy of the selected journal articles in advance.
PREVIOUS SESSIONS
Case Conversation: COVID-19 Vaccination and ITP
2/28/23 12:00 p.m. - 1:00 p.m. ET
This is a recorded version of the webinar on Case Conversation: COVID-19 Vaccination and ITP that was presented live on February 28, 2023. This program was presented by Dr. Hanny Al-Samkari and moderated by Dr. James Bussel
Case Conversation: Iron Deficiency and Fatigue Among Adolescents with Bleeding Disorders
1/31/23 12:00 p.m. - 1:00 p.m. ET
This is a recorded version of the webinar on Case Conversation: Iron Deficiency and Fatigue Among Adolescents with Bleeding Disorders that was presented live on January 31, 2023. This program was presented by Dr. Ayesha Zia and Dr. Sarah O’Brien.
Case Conversation: Safety and Efficacy of Classical Complement Pathway Inhibition with Sutimlimab in Chronic Immune Thrombocytopenia
11/9/22 12:00 p.m. - 1:00 p.m. ET
This is a recorded version of the webinar on Case Conversation: Safety and Efficacy of Classical Complement Pathway Inhibition with Sutimlimab in Chronic Immune Thrombocytopenia that was presented live on November 9, 2022. This program was presented by Dr. Catherine Broome and was moderated by Dr. James Bussel. The production, accreditation and archiving of this program were made possible through a sponsorship from Sobi.
Case Conversation: An Update on Pediatric Immune Thrombocytopenia (ITP): Differentiating Primary ITP, IPD, and PID
5/24/22 12:00 p.m. - 1:00 p.m. ET
This is a recorded version of the Journal Club program Case Conversation: An Update on Pediatric Immune Thrombocytopenia (ITP): Differentiating Primary ITP, IPD, and PID. This program was presented by Dr. Michele Lambert and was moderated by Dr. Rachael Grace. The production, accreditation and archiving of this program were made possible through a sponsorship from Sobi.
Case Conversation: Sex Dimorphism in Trauma-Induced Coagulopathy
12/17/2021 12:00 p.m. - 1:00 p.m. ET
This is a recorded version of the webinar Case Conversation: Sex Dimorphism in Trauma-Induced Coagulopathy. This webinar was presented by Dr. Julia Coleman, Dr. Gene Moore, and was moderated by Dr. Kenneth Mann. It took place on December 17, 2021.
Case Conversation: Contraceptive Use and Preferences in Females with Sickle Cell Disease
10/29/2021 12:00 p.m. - 1:00 p.m. ET
This is a recorded version of Case Conversation: Contraceptive Use and Preferences in Females with Sickle Cell Disease. This program was presented by Dr. Andrea Roe, and was moderated by Dr. Tami Chrisentery-Singleton. It took place on October 29, 2021. A copy of the recording may be obtained by contacting Kerry Funkhouser.
Case Conversation: New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
8/25/2021 1:00 p.m. - 2:00 p.m. ET
This is a recorded version of the first Case Conversation: New Developments in Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). This program was presented by Dr. Jim Bussel and Dr. Emilie Vander Haar, and was moderated by Dr. Andra James and Kim Roque. It took place on August 25, 2021. The production and archiving of this program were made possible in part by an educational grant from Janssen.